Home   Categories   Grid

Subscribe Now

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

25 January 2019

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive


£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

19 January 2019

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform


A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

14 January 2019

We tour the striking building that could redefine what a pharma business looks like


Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

10 January 2019

Companies sign agreement for Lightning-Link Rapid Biotin technology


Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

10 January 2019

Next-generation immuno-oncology candidate triggers AstraZeneca payment


How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

09 January 2019

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company


Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

08 January 2019

Company says it is preparing for no-deal Brexit


AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

07 January 2019

CEO Pascal Soriot says company expects 'sustained growth' period as new R&D units and commercial units created


PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

04 January 2019

Genomics data compression firm was spun out of university in 2016


Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

30 December 2018

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge


Morphogen-IX: £18.4m boost for PAH medicine

Morphogen-IX: £18.4m boost for PAH medicine

Morphogen-IX: £18.4m boost for PAH medicine

27 December 2018

Pulmonary arterial hypertension (PAH) investment for preclinical trials of disease-modifying MGX292 drug candidate


Success of Accelerate@Babraham bio-incubator programme is showcased

Success of Accelerate@Babraham bio-incubator programme is showcased

Success of Accelerate@Babraham bio-incubator programme is showcased

23 December 2018

The first bio-incubator programme at the campus has given some exciting companies a significant boost


NHS prepares for genetic services era

NHS prepares for genetic services era

NHS prepares for genetic services era

13 December 2018

Cambridge-based Congenica underpins genomic service


AstraZeneca and CRUK launch Cambridge centre to accelerate cancer drug development

AstraZeneca and CRUK launch Cambridge centre to accelerate cancer drug development

AstraZeneca and CRUK launch Cambridge centre to accelerate cancer drug development

10 December 2018

The Functional Genomics Centre on Cambridge Biomedical Campus aims to improve our understanding of cancer biology


Shocking mistreatment of mother in rare disease case

Shocking mistreatment of mother in rare disease case

Shocking mistreatment of mother in rare disease case

09 December 2018

"It's about changing the narrative from reactive to proactive" said Rebecca Pinder at RAREfest


F-star and AstraZeneca win at the Scrip Awards 2018

F-star and AstraZeneca win at the Scrip Awards 2018

F-star and AstraZeneca win at the Scrip Awards 2018

07 December 2018

Biopharmaceutical companies among winners for major deals


RAREfest brings life sciences to Guildhall

RAREfest brings life sciences to Guildhall

RAREfest brings life sciences to Guildhall

06 December 2018

'We have found our tribe', say families at rare disease weekend


eLife announces partnership to develop its research communications platform Libero

eLife announces partnership to develop its research communications platform Libero

eLife announces partnership to develop its research communications platform Libero

06 December 2018

Cambridge non-profit teams up with Coko, open-access publisher Hindawi Limited and digital consultancy Digirati


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More